About Implantica



Implantica’s executive team includes the core management of Obtech Medical AG complemented by an experienced team with a track record of over 20 years of leading publicly listed and healthcare companies.

Dr. Peter Forsell – CEO

Dr. Forsell was the Executive Chairman of Obtech Medical AG, the team’s previous successful medical technology business which commercialized the SAGB, an adjustable gastric band to treat obesity that Dr. Forsell developed. The total gastric banding market peaked at 42% market share of all obesity surgery.  Dr. Forsell has gained extensive experience during this long journey how to lead and develop a business from inception to a successful global enterprise. Obtech was later sold for a significant amount to a leading healthcare company.

As CEO of Implantica, he is focused on guiding Implantica to the next level.

Dr. Forsell is an internationally renowned surgeon and the brain behind Implantica’s decade of patent and development work focusing on how to move advanced technology into the body. He is the inventor and originator of most of Implantica’s products and the large patent portfolio of >1’000 patent cases. This includes IM RefluxStop™, a device obtaining CE mark after a very successful clinical trial and will cause a potential paradigm shift in the treatment of acid reflux. Dr. Forsell is a specialist in surgery at the Karolinska Hospital, and he obtained his medical degree at the Karolinska Institute in Stockholm, Sweden. He has also studied basic law, tax and finance.

Dr. Lorenzo Trezzini – CFO

Dr. Trezzini, 1968, Swiss Citizen, has more than 20 years finance leadership experience in Europe and US, 9 of them as Group CFO for SIX Swiss Exchange listed companies. Dr. Trezzini was Group CFO of the SIX Swiss Exchange listed Valora Holding AG as well as of the SIX Swiss listed Valartis Group and member of the executive committees of the Valartis Bank AG. During his professional career he was Manager with Deloitte in New York and Zurich and worked at Ernst & Young in corporate finance. Dr. Trezzini holds an MBA and PhD from the University of Zurich and is a Swiss CPA. Dr. Trezzini is Member of the Board of Directors of Kieger Luxembourg SA (2015) as well as of Limmat Capital Alternative Investment AG (2016).

Stephan Siegenthaler – Chief Strategy Officer

Mr. Siegenthaler was the co-founder and former Managing Director of Obtech Medical AG, the team’s previous successful medical technology business in obesity surgery. At Obtech Medical, he guided the company to success, reaching 28% non-US market share of all obesity surgery. He built a global sales organization, established a sales force in 32 countries and developed close relationships with Key Opinion Leaders all over the world. Mr. Siegenthaler’s vast surgical contact network and experience in healthcare management  contribute considerably to Implantica’s ambition of a rapid IM RefluxStop™ market launch, guiding the company to its next phase.